Rady Pediatric Genomics & Systems Medicine Institute
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Rady Pediatric Genomics & Systems Medicine Institute sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).
Rady Pediatric Genomics & Systems Medicine Institute: 6 sponsored US clinical trials, 4 recruiting.
Rady Pediatric Genomics & Systems Medicine Institute sponsors 6 registered US clinical trials on ClinicalTrials.gov, 4 of them currently recruiting, and 2 completed. The most-studied condition in this pipeline is Genetic Diseases, with 1 trials.
Upper-quartile sponsor footprint
Rady Pediatric Genomics & Systems Medicine Institute sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
6 total, page 1 of 1
An Adaptive Clinical Trial of BeginNGS Newborn Screening for Hundreds of Genetic Diseases by Genome Sequencing
NCT06306521
Mental Health Crises in Youth With IDDs
NCT05471232
Multiomic Diagnostics in Youth With Psychosis
NCT05457140
Rady Children's Institute Genomic Biorepository
NCT02917460
ASD Wearables Feasibility Study
NCT07504224
Newborn Genomic Sequencing Pilot Study
NCT06276348
Therapeutic Areas
What is open in the Rady Pediatric Genomics & Systems Medicine Institute pipeline
4 recruiting of 6 indexed (67% open); 2 completed (33%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Genetic Diseases (1 trial), 3 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Rady Pediatric Genomics & Systems Medicine Institute: open-pipeline peers nationwide
Peers matched on 6 registered trials and 67% open enrollment, not the therapeutic-area sidebar.
Rady Pediatric Genomics & Systems Medicine Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 6 trials (± recruiting share)
- 23andMe · 6 trials · 0% recruiting
- Aardvark Therapeutics · 6 trials · 0% recruiting
- Abbisko Therapeutics Co · 6 trials · 67% recruiting
- AbGenomics B.V Taiwan Branch · 6 trials · 0% recruiting
Sponsors near 67% open enrollment (± trial volume)
- ABL Bio · 67% recruiting · 3 trials
- Accelerated Cure Project for Multiple Sclerosis · 67% recruiting · 3 trials
- Advanced Reconstructive Surgery Alliance · 67% recruiting · 3 trials
- Alexander B Olawaiye, MD · 67% recruiting · 3 trials
Related
What to do with this Rady Pediatric Genomics & Systems Medicine Institute page
6 registered trials is a research-attention snapshot, not an endorsement of Rady Pediatric Genomics & Systems Medicine Institute or any single study.
- 4 of Rady Pediatric Genomics & Systems Medicine Institute's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Genetic Diseases is the condition Rady Pediatric Genomics & Systems Medicine Institute studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Genetic Diseases trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Rady Pediatric Genomics & Systems Medicine Institute pipeline card: 6 registered trials from official public datasets.Report a data error.